Health and Fitness Health and Fitness
Tue, November 8, 2011
[ Tue, Nov 08th 2011 ] - Market Wire
30 AM EST
Mon, November 7, 2011
[ Mon, Nov 07th 2011 ] - Market Wire
30 a.m. ET
Sun, November 6, 2011
Sat, November 5, 2011
Fri, November 4, 2011
Thu, November 3, 2011
Wed, November 2, 2011
Tue, November 1, 2011
Mon, October 31, 2011
Sat, October 29, 2011
Fri, October 28, 2011
Thu, October 27, 2011
Wed, October 26, 2011
Tue, October 25, 2011
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
Sat, October 22, 2011
Fri, October 21, 2011

Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company


//health-fitness.news-articles.net/content/2011/ .. investigation-of-k-v-pharmaceutical-company.html
Published in Health and Fitness on Friday, October 28th 2011 at 13:41 GMT by Market Wire   Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at K-V Pharmaceutical Company (aK-Va or the aCompanya) (NYSE: KV-A) (NYSE: KV-B). Faruqi & Faruqi, LLP seeks to determine whether certain officers and directors at K-V violated federal securities laws in connection with statements made to the Company's shareholders.

Request more information now by clicking here: [ www.faruqilaw.com/KV ].

The investigation focuses on whether certain individuals violated federal securities laws by, among other things, failing to disclose that: (1) the Company had inaccurately claimed that the Food and Drug Administration (the aFDAa) was granting K-V the exclusive distribution rights over aMakena,a a drug used to prevent miscarriages; (2) the FDA would not be enforcing K-Vas rights by preventing the Companyas competitors from distributing generic formulations of the drug; and (3) the drugas $1,500 price would reduce the availability of Makena to low-income and other at-risk groups.

On March 30, 2011, the FDA revealed that it did not intend to take enforcement action against K-Vas competitors for distributing generic versions of K-Vas Makena.

Take Action

If you purchased K-V securities between February 14, 2011 and April 4, 2011 and you would like to discuss your legal rights, visit [ www.faruqilaw.com/KV ]. You can also contact us by calling Anthony Vozzolo or Richard W. Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [ avozzolo@faruqilaw.com ] or [ rgonnello@faruqilaw.com ]. Faruqi & Faruqi, LLP also encourages anyone with information regarding K-V's conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP is a national law firm, representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide.

Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ([ www.faruqilaw.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.


Publication Contributing Sources